Gilead Makes Exclusive Deal With CVS for Hepatitis C Drugs (2)
Alert: HALISTER Source: BN (Bloomberg News)
Tickers GILD US (Gilead Sciences Inc) CVS US (CVS Health Corp) ABBV US (AbbVie Inc)
People Alex Arfaei (Bank of Montreal) Michael J Yee (RBC Capital Markets) Robyn Karnauskas (Deutsche Bank AG)
Topics Viral Hepatitis
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283